KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Interest & Investment Income (2017 - 2025)

Guardant Health's Interest & Investment Income history spans 9 years, with the latest figure at $10.0 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 13.91% year-over-year to $10.0 million; the TTM value through Dec 2025 reached $34.1 million, down 36.5%, while the annual FY2025 figure was $34.1 million, 36.5% down from the prior year.
  • Interest & Investment Income for Q4 2025 was $10.0 million at Guardant Health, up from $7.4 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $14.9 million in Q1 2024 and bottomed at $653000.0 in Q4 2021.
  • The 5-year median for Interest & Investment Income is $7.1 million (2023), against an average of $6.7 million.
  • The largest annual shift saw Interest & Investment Income crashed 70.21% in 2021 before it skyrocketed 566.48% in 2023.
  • A 5-year view of Interest & Investment Income shows it stood at $653000.0 in 2021, then skyrocketed by 229.25% to $2.2 million in 2022, then skyrocketed by 545.95% to $13.9 million in 2023, then fell by 16.09% to $11.7 million in 2024, then dropped by 13.91% to $10.0 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Interest & Investment Income are $10.0 million (Q4 2025), $7.4 million (Q3 2025), and $7.6 million (Q2 2025).